应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03320 华润医药
耶稣受难节休市 03-28 16:08:03
5.000
-0.090
-1.77%
最高
5.070
最低
4.920
成交量
1,484万
今开
5.060
昨收
5.090
日振幅
2.95%
总市值
314.13亿
流通市值
314.13亿
总股本
62.83亿
成交额
7,394万
换手率
0.24%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华润医药03月28日遭主力抛售678万元 环比增加868.57%
自选股智能写手 · 03-28 16:16
华润医药03月28日遭主力抛售678万元 环比增加868.57%
海通国际:维持华润医药“优于大市”评级 目标价8.12港元
新浪港股 · 03-27 17:45
海通国际:维持华润医药“优于大市”评级 目标价8.12港元
海通国际:维持华润医药(03320)“优于大市”评级 目标价8.12港元
智通财经 · 03-27 17:05
海通国际:维持华润医药(03320)“优于大市”评级 目标价8.12港元
华润医药2023年实现净利38.54亿元
北京商报官方账号 · 03-26
华润医药2023年实现净利38.54亿元
华润医药2023年营收同比增长12.2%
北京商报官方账号 · 03-26
华润医药2023年营收同比增长12.2%
华润医药2023年纯利增长10.1%至38.54亿元
观点新媒体 · 03-26
华润医药2023年纯利增长10.1%至38.54亿元
华润医药将于7月19日派发末期股息每股0.154元
新浪港股 · 03-26
华润医药将于7月19日派发末期股息每股0.154元
华润医药发布2023年度业绩 股东应占溢利38.54亿元同比增长10.11%
新浪港股 · 03-26
华润医药发布2023年度业绩 股东应占溢利38.54亿元同比增长10.11%
华润医药(03320.HK)年度纯利增10.1%至38.54亿元 末期息0.154元
格隆汇资讯 · 03-26
华润医药(03320.HK)年度纯利增10.1%至38.54亿元 末期息0.154元
【港股通】华润医药(03320)去年溢利增长10%至38.54亿元 拟派末期股息0.154元
金吾财讯 · 03-26
【港股通】华润医药(03320)去年溢利增长10%至38.54亿元 拟派末期股息0.154元
华润医药(03320)发布年度业绩,股东应占溢利38.54亿元,同比增长10.11%,拟派末期息每股0.154元
智通财经 · 03-26
华润医药(03320)发布年度业绩,股东应占溢利38.54亿元,同比增长10.11%,拟派末期息每股0.154元
《公司业绩》华润医药(03320.HK)全年纯利38.5亿人币升10% 末期息16港仙
阿斯达克财经 · 03-26
《公司业绩》华润医药(03320.HK)全年纯利38.5亿人币升10% 末期息16港仙
华润医药(03320)将于7月19日派发末期股息每股0.154元
智通财经网 · 03-26
华润医药(03320)将于7月19日派发末期股息每股0.154元
华润医药:华润博雅生物2023年度净利润2.37亿元 同比下降45.06%
新浪港股 · 03-25
华润医药:华润博雅生物2023年度净利润2.37亿元 同比下降45.06%
华润医药:江中药业2023年度归母净利润7.08亿元 同比增长18.4%
新浪港股 · 03-25
华润医药:江中药业2023年度归母净利润7.08亿元 同比增长18.4%
【港股通】华润医药(03320):华润博雅生物去年溢利降45.06%至2.37亿元人民币 拟10派3元
金吾财讯 · 03-25
【港股通】华润医药(03320):华润博雅生物去年溢利降45.06%至2.37亿元人民币 拟10派3元
【港股通】华润医药(03320):江中药业去年溢利升18.40%至7.08亿元人民币 拟10派7元
金吾资讯 · 03-25
【港股通】华润医药(03320):江中药业去年溢利升18.40%至7.08亿元人民币 拟10派7元
【港股通】华润医药(03320):华润三九去年溢利升16.50%至28.53亿元人民币 拟10转3派15元
金吾财讯 · 03-25
【港股通】华润医药(03320):华润三九去年溢利升16.50%至28.53亿元人民币 拟10转3派15元
华润医药(03320):华润博雅生物(300294.SZ)2023年度净利润2.37亿元 同比下降45.06%
智通财经 · 03-25
华润医药(03320):华润博雅生物(300294.SZ)2023年度净利润2.37亿元 同比下降45.06%
华润医药(03320):江中药业(600750.SH)年度归母净利润7.08亿元,同比增长18.4%
智通财经网 · 03-25
华润医药(03320):江中药业(600750.SH)年度归母净利润7.08亿元,同比增长18.4%
加载更多
公司概况
公司名称:
华润医药
所属市场:
SEHK
上市日期:
--
主营业务:
华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。
发行价格:
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":5,"timestamp":1711613283016,"preClose":5.09,"halted":0,"volume":14838007,"delay":0,"floatShares":6282510461,"shares":6282510461,"eps":0.6618601,"marketStatus":"耶稣受难节休市","marketStatusCode":7,"change":-0.09,"latestTime":"03-28 16:08:03","open":5.06,"high":5.07,"low":4.92,"amount":73939396,"amplitude":0.02947,"askPrice":5.01,"askSize":19500,"bidPrice":5,"bidSize":217000,"shortable":3,"etf":0,"ttmEps":0.6618601110050244,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1712021400000},"adr":0,"listingDate":1477584000000,"adjPreClose":5.09,"dividendRate":0.033202,"openAndCloseTimeList":[[1711589400000,1711598400000],[1711602000000,1711612800000]],"volumeRatio":1.5090795940874229,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320/","defaultTab":"news","newsList":[{"id":"2422879158","title":"华润医药03月28日遭主力抛售678万元 环比增加868.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422879158","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422879158?lang=zh_cn&edition=full","pubTime":"2024-03-28 16:16","pubTimestamp":1711613790,"startTime":"0","endTime":"0","summary":"03月28日, 华润医药股价跌1.77%,报收5.00元,成交金额7393万元,换手率0.24%,振幅2.95%,量比1.50。华润医药今日主力资金净流出678万元,上一交易日主力净流出70万元,今日环比增加868.57%。该股近5个交易日下跌4.22%,主力资金累计净流出564万元;近20日主力资金累计净流出3712万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032816172587bfbae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032816172587bfbae9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422968087","title":"海通国际:维持华润医药“优于大市”评级 目标价8.12港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422968087","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422968087?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:45","pubTimestamp":1711532700,"startTime":"0","endTime":"0","summary":" 海通国际发布研究报告称,维持华润医药“优于大市”评级,目标价8.12港元。预计2024-26年将分别实现收入2710/2993/3298亿元人民币,对应增速分别为10.8%/10.4%/10.2%;将分别实现归母净利润42.87/47.49/52.41亿人民币,对应增速分别为11.2%/10.8%/10.4%。该行认为集团通过外延并购积极拓展业务版图,同时持续整合内部资源实现协同,旗下子公司股权激励计划均有序施行,将助力集团实现可持续的稳健增长。股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tob/2024-03-27/doc-inapufqp5441154.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2024-03-27/doc-inapufqp5441154.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422807957","title":"海通国际:维持华润医药(03320)“优于大市”评级 目标价8.12港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422807957","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422807957?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:05","pubTimestamp":1711530356,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,海通国际发布研究报告称,维持华润医药(03320)“优于大市”评级,目标价8.12港元。预计2024-26年将分别实现收入2710/2993/3298亿元人民币,对应增速分别为10.8%/10.4%/10.2%;将分别实现归母净利润42.87/47.49/52.41亿人民币,对应增速分别为11.2%/10.8%/10.4%。该行认为集团通过外延并购积极拓展业务版图,同时持续整合内部资源实现协同,旗下子公司股权激励计划均有序施行,将助力集团实现可持续的稳健增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093387.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422664642","title":"华润医药2023年实现净利38.54亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422664642","media":"北京商报官方账号","top":-1,"share":"https://www.laohu8.com/m/news/2422664642?lang=zh_cn&edition=full","pubTime":"2024-03-26 18:09","pubTimestamp":1711447762,"startTime":"0","endTime":"0","summary":"北京商报讯(记者 丁宁)3月26日晚间,华润医药(03320.HK)发布2023年全年业绩公告显示,公司2023年实现营业收入约为2447.04亿元,同比增长12.16%;对应实现的归属净利润约为38.54亿元,同比增长10.11%。资料显示,华润医药是中国领先的综合医药公司,主要从事医药研发、制造、分销及零售等业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261810098b64dc7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261810098b64dc7c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422665325","title":"华润医药2023年营收同比增长12.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422665325","media":"北京商报官方账号","top":-1,"share":"https://www.laohu8.com/m/news/2422665325?lang=zh_cn&edition=full","pubTime":"2024-03-26 17:09","pubTimestamp":1711444159,"startTime":"0","endTime":"0","summary":"在医药分销业务方面,华润医药加快动物保健领域分销业务的布局,获得一个2023年新获批上市的猫三联灭活疫苗全国总代理权益;在医药零售业务方面,华润医药集团共有790家自营零售药房,其中DTP专业药店总数达272家。2023年1月,华润三九收购昆药集团28%股权,成为其控股股东,加强中药业务竞争力。2023年12月,华润医药集团完成收购附属公司华润江中约9.21%股份,所持有的股份增加至约60.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261709548b64ab67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261709548b64ab67&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422165669","title":"华润医药2023年纯利增长10.1%至38.54亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422165669","media":"观点新媒体","top":-1,"share":"https://www.laohu8.com/m/news/2422165669?lang=zh_cn&edition=full","pubTime":"2024-03-26 14:47","pubTimestamp":1711435635,"startTime":"0","endTime":"0","summary":"观点网讯:3月26日,华润医药公布截至2023年底全年业绩,纯利达38.54亿元人民币,同比增长10.1%。每股盈利0.61元,并派发末期息16港仙。期内,集团营业额2447.04亿元,年增12.2%,其中制药、医药分销、药品零售三业务板块收益占比分别为16.0%、80.0%及3.9%。该集团报告期内毛利383.37亿元,较去年同期上升14%,整体毛利率提升至15.7%,增加0.3个百分点。这一变化主要得益于制药业务毛利率的提高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032614475787b656eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032614475787b656eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422362046","title":"华润医药将于7月19日派发末期股息每股0.154元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422362046","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422362046?lang=zh_cn&edition=full","pubTime":"2024-03-26 12:50","pubTimestamp":1711428611,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布公告,将于2024年7月19日派发截至2023年12月31日止年度的末期股息每股人民币0.154元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-26/doc-inaprmtq3921822.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-26/doc-inaprmtq3921822.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422163678","title":"华润医药发布2023年度业绩 股东应占溢利38.54亿元同比增长10.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422163678","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422163678?lang=zh_cn&edition=full","pubTime":"2024-03-26 12:49","pubTimestamp":1711428565,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布截至2023年12月31日止年度业绩,收益2447.04亿元(人民币,下同),同比增长12.16%;公司权益持有人应占溢利38.54亿元,同比增长10.11%;每股盈利0.61元;拟派发末期股息每股0.154元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-26/doc-inaprmtq3921728.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-26/doc-inaprmtq3921728.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422636243","title":"华润医药(03320.HK)年度纯利增10.1%至38.54亿元 末期息0.154元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422636243","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2422636243?lang=zh_cn&edition=full","pubTime":"2024-03-26 12:48","pubTimestamp":1711428510,"startTime":"0","endTime":"0","summary":"格隆汇3月26日丨华润医药公布年度业绩,截至2023年12月31日止年度,集团录得总收益达人民币2447.039亿元,较2022年总收益人民币2181.830亿元增长12.2%。报告期间内,集团实现毛利人民币383.375亿元,较2022年的毛利人民币336.191亿元增长14.0%。董事会建议派付末期股息每股人民币0.154元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261248348b63d15d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403261248348b63d15d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422635272","title":"【港股通】华润医药(03320)去年溢利增长10%至38.54亿元 拟派末期股息0.154元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422635272","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2422635272?lang=zh_cn&edition=full","pubTime":"2024-03-26 12:19","pubTimestamp":1711426784,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药 公布,截至2023年12月31日止年度,公司权益持有人应占溢利38.54亿元,同比增长10.11%;每股基本盈利0.61元。其中,医药分销业务实现分部收益2021.54亿元,同比增长11.4%。分销业务毛利率为5.9%,较上年同期微降0.2个百分点。整体毛利率为15.7%,同比增长0.3个百分点,主要受益于报告期间内制药业务毛利率水平提升拉动。期内,集团研发总支出约25.04亿元,同比增长12.6%。截至报告期末,集团新产品在研项目超过330个,其中新药项目近100个。","market":"us","thumbnail":"https://static.szfiu.com/news/20200915/MjU2ODc5N2YyZTE5MjdiOGJhODAwMDc0ODU4NjQ4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/MjU2ODc5N2YyZTE5MjdiOGJhODAwMDc0ODU4NjQ4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1934048","is_publish_highlight":false,"gpt_icon":0},{"id":"2422363310","title":"华润医药(03320)发布年度业绩,股东应占溢利38.54亿元,同比增长10.11%,拟派末期息每股0.154元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422363310","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422363310?lang=zh_cn&edition=full","pubTime":"2024-03-26 12:14","pubTimestamp":1711426472,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药 发布截至2023年12月31日止年度业绩,收益2447.04亿元,同比增长12.16%;公司权益持有人应占溢利38.54亿元,同比增长10.11%;每股盈利0.61元;拟派发末期股息每股0.154元。报告期间内,集团实现毛利383.38亿元,同比增长14%。2023年,集团实现净利润77.75亿元,同比增长16.8%。集团实现公司拥有人应占溢利38.54亿元,同比增长10.1%;剔除附属公司处置、与投资相关的减值等一次性项目影响,报告期间内公司拥有人应占溢利同比稳健增长21.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092164.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422908635","title":"《公司业绩》华润医药(03320.HK)全年纯利38.5亿人币升10% 末期息16港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2422908635","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422908635?lang=zh_cn&edition=full","pubTime":"2024-03-26 12:12","pubTimestamp":1711426320,"startTime":"0","endTime":"0","summary":"华润医药公布截至去年12月底止全年业绩。纯利38.54亿元人民币(下同),按年升10.1%;每股盈利0.61元。派末期息16港仙,与上年同期相同。过往派息公布日期派息事项派息内容2023/10/31第三季业绩无派息2023/08/31中期业绩无派息2023/03/30末期业绩普通股息:港元 0.16002022/08/25中期业绩无派息 期内,集团营业额2,447.04亿元,按年升12.2%。当中制药、医药分销、药品零售三个主要业务分部的收益占比分别为16.0%、80.0%以及3.9%。沽空资料截至 2024-03-25 16:25。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210624132643319_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210624132643319_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337026/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422633658","title":"华润医药(03320)将于7月19日派发末期股息每股0.154元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422633658","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422633658?lang=zh_cn&edition=full","pubTime":"2024-03-26 12:10","pubTimestamp":1711426220,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布公告,将于2024年7月19日派发截至2023年12月3...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_22.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_22.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092159.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422874425","title":"华润医药:华润博雅生物2023年度净利润2.37亿元 同比下降45.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422874425","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422874425?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:17","pubTimestamp":1711329421,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布公告,该集团附属公司华润博雅生物(300294.SZ)截至2023年12月31日止年度取得营业总收入人民币26.52亿元(单位下同),同比下降3.87%;归属于上市公司股东的净利润2.37亿元,同比下降45.06%;每股基本盈利0.47元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnwez0131475.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnwez0131475.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422874825","title":"华润医药:江中药业2023年度归母净利润7.08亿元 同比增长18.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422874825","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422874825?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:15","pubTimestamp":1711329358,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布江中药业(600750.SH)截至2023年12月31日止年度业绩,江中药业于2023年度实现营业总收入约43.9亿元(人民币,下同),同比增长13%;上市公司股东应占净利润7.08亿元,同比增长18.4%;每股基本盈利1.12元/股,拟每10股分配现金股息7元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnweu5100882.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inapnweu5100882.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422581713","title":"【港股通】华润医药(03320):华润博雅生物去年溢利降45.06%至2.37亿元人民币 拟10派3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422581713","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2422581713?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:30","pubTimestamp":1711326619,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公布,2023年度,公司附属公司华润博雅生物上市公司股东应占净利润2.37亿元(人民币,下同),同比减少45.06%;每股基本盈利0.47元,同比减少45.35%。经华润博雅生物董事会决定,华润博雅生物建议以实施权益分派股权登记日登记的总股本为基数,向全体华润博雅生物股东分派现金股息每10股人民币3元(含税)。期内,华润博雅生物实现营业总收入26.52亿元,同比减少3.87%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1933913","is_publish_highlight":false,"gpt_icon":0},{"id":"2422158178","title":"【港股通】华润医药(03320):江中药业去年溢利升18.40%至7.08亿元人民币 拟10派7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422158178","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2422158178?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:30","pubTimestamp":1711326600,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公布,2023年度,公司附属公司江中药业上市公司股东应占净利润7.08亿元(人民币,下同),同比增长18.40%;每股基本盈利1.12元,同比增长17.89%。经江中药业董事会决定,江中药业建议以实施权益分派股权登记日江中药业总股本为基数,向全体江中药业股东分派现金股息,每10股分配现金股息人民币7元(含税)。期内,江中药业实现营业总收入43.9亿元,同比增长13.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032508300887b09cc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032508300887b09cc7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422858171","title":"【港股通】华润医药(03320):华润三九去年溢利升16.50%至28.53亿元人民币 拟10转3派15元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422858171","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2422858171?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:29","pubTimestamp":1711326577,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公布,2023年度,公司附属公司华润三九上市公司股东应占净利润28.53亿元(人民币,下同),同比增长16.50%;每股基本盈利2.90元,同比增长16.94%。经华润三九董事会决定,华润三九建议以实施权益分派股权登记日登记的总股本为基数,向全体华润三九股东分派现金股息每10股人民币15元(含税),以资本公积金向全体华润三九股东每10股转增3股。期内,华润三九实现营业总收入247.39亿元,同比增长36.83%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/ZjY2YjQxYzhiZWM4YjljOTY5ZWUyMTU0MTAyMDMwNzUxNzY3MzQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZjY2YjQxYzhiZWM4YjljOTY5ZWUyMTU0MTAyMDMwNzUxNzY3MzQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1933911","is_publish_highlight":false,"gpt_icon":0},{"id":"2422158116","title":"华润医药(03320):华润博雅生物(300294.SZ)2023年度净利润2.37亿元 同比下降45.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422158116","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422158116?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:26","pubTimestamp":1711326402,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,该集团附属公司华润博雅生物(300294.SZ)截至2023年12月31日止年度取得营业总收入人民币26.52亿元(单位下同),同比下降3.87%;归属于上市公司股东的净利润2.37亿元,同比下降45.06%;每股基本盈利0.47元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091192.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422581571","title":"华润医药(03320):江中药业(600750.SH)年度归母净利润7.08亿元,同比增长18.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422581571","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422581571?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:21","pubTimestamp":1711326101,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布江中药业(600750.SH)截至2023年12月31日止年度业绩,江中药业于2023年度实现营业总收入约43.9亿元(人民币,下同),同比增长13%;上市公司股东应占净利润7.08亿元,同比增长18.4%;每股基本盈利1.12元/股,拟每10股分配现金股息7元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091189.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.0403},{"period":"1month","weight":-0.0566},{"period":"3month","weight":-0.0253},{"period":"6month","weight":-0.0385},{"period":"1year","weight":-0.2951},{"period":"ytd","weight":-0.0253}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0149},{"period":"3month","weight":-0.0297},{"period":"6month","weight":-0.0712},{"period":"1year","weight":-0.1808},{"period":"ytd","weight":-0.0297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008421},{"month":2,"riseRate":0.75,"avgChangeRate":0.05498},{"month":3,"riseRate":0.5,"avgChangeRate":-0.024129},{"month":4,"riseRate":0.857143,"avgChangeRate":0.058624},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.012229},{"month":6,"riseRate":0.428571,"avgChangeRate":0.007002},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.05379},{"month":8,"riseRate":0.428571,"avgChangeRate":0.008896},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.04297},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.027807},{"month":11,"riseRate":0.5,"avgChangeRate":0.023267},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003044}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}